Clinical and Laboratory Features of COVID-19 in Ulin Referral Hospital of South Kalimantan: Predictors of Clinical Outcome

Haryati Haryati, Mohamad Isa, Ali Assagaf, Ira Nurrasyidah, Erna Kusumawardhani, Eko Suhartono, Fidya Rahmadhany Arganita


Corona Virus Disease (COVID-19) is becoming a global pandemic. Indonesia, especially South Kalimantan had recorded increasing cases with a high fatality rate of 3.7%. Information about factors related to outcomes based on clinical and laboratory features in Indonesia is still limited. Identification of the risk is crucial to determine optimal management and reducing mortality. This retrospective study enrolled 455 adults COVID-19 patients, and data were extracted from medical records of Ulin General Hospital Banjarmasin. The latter is COVID-19 referral hospital in South Kalimantan between March-November 2020. Demographic data, comorbidities, and laboratory were all collected. Data were compared between survivors and non-survivors. Fisher’s exact test and chi-square were used to compare categorical variables. The Mann_Whitney U test was used to compare continuous variables. Analysis was continued by multivariate logistic regression then receiver operating characteristic (ROC) curve to determine cut-off value. The multivariate analysis showed that number of comorbidities [odds ratio (OR) 1,339 (95% confidence interval (CI): 1,064-1,685, P = 0,013) was a significant risk factor to the outcome. In laboratory, lactate dehydrogenase (LDH) [OR: 1.001, 95% CI: 1,000-1.002, P = 0.001], Ferritin (OR 1.000, CI: 1,000-1.001, P = 0.013), APTT (OR: 1.045, CI: 1.010-1.082, P = 0.012), and D-dimer (OR: 1.188, CI: 1.064 - 1.327, P = 0.002) were significant predictor factors but only LDH, ferritin, and D- dimer were obtained good AUC 0.731, 0.715, and 0.705, respectively. The cut of the value of LDH was 656.5 U/L, ferritin was 672.18 ng/ml, and D-dimer was 2.28 mg/L. Sensitivity and specificity were 66.7% and 68,0% for LDH, 83,2% and 56,3% for ferritin, and 62,8 and 70,8% for D-dimer. From this research, we revealed that the number of comorbidities was a risk factor for death. Elevated LDH, ferritin, and D-dimer could be good predictive factors for poor outcomes, thereby considering the accelerating management of COVID-19 patients.


COVID-19, Comorbidities, LDH, Ferritin, D-dimer, Outcome

Full Text:



World Health Organization (2021) Coronavirus disease (COVID-19) Pandemic. (2021)Accessed: January 2021.

Cucinotta D, Vanelli M (2020) WHO declares COVID-19 a pandemic. Acta Biomed. doi: 10.23750/abm.v91i1.9397

Kemenkes (2021) Situasi Terkini Perkembangan Coronavirus Disease (COVID-19) 21 Januari 2021. perkembangan-coronavirus-disease-covid-19-21-januari-2021. (2021)Accessed: January 2021.

da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM et al. (2020) Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. doi: 10.1007/s00508-020-01760-4

Adhikari SP, Meng S, Wu YJ et al. (2020) Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty. doi: 10.1186/s40249-020-00646-x

Khedr EM, Daef E, Mohamed-Hussein A et al. (2020) Impact of comorbidities on COVID-19 outcome. medRxiv. doi: 10.1101/2020.11.28.20240267

Guan W, Ni Z, Hu Y et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine 382 (18): 1708–1720. doi: 10.1056/nejmoa2002032.

Mauvais-Jarvis F (2020) Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19. Diabetes 69 (9): 1857–1863. doi: 10.2337/dbi19-0023.

Peckham H, de Gruijter NM, Raine C et al. (2020) Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nature Communications 11 (1): 1–10. doi: 10.1038/s41467-020-19741-6.

Kragholm K, Andersen MP, Gerds TA et al. (2020) Association Between Male Sex and Outcomes of Coronavirus Disease 2019 (COVID-19)—A Danish Nationwide, Register-based Study. Clinical Infectious Diseases 2019 (Xx): 1–6. doi: 10.1093/cid/ciaa924.

Allali G, Marti C, Grosgurin O et al. (2020) Dyspnea: The vanished warning symptom of COVID-19 pneumonia. Journal of Medical Virology 92 (11): 2272–2273. doi: 10.1002/jmv.26172.

Tjahyadi RM, Astuti T, Listyoko AS (2020) COVID-19 :Correlation Between CRP and LDH to Disease Severity and Mortality In Hospitalized COVID-19 Patients. Medica Hospitalia : Journal of Clinical Medicine 7 (1A): 144–149. doi: 10.36408/mhjcm.v7i1a.467.

Dong X, Sun L, Li Y (2020) Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with covid-19. International Journal of Medical Sciences 17 (14): 2225–2231. doi: 10.7150/ijms.47604.

Schett G, Sticherling M, Neurath MF (2020) COVID-19: risk for cytokine targeting in chronic inflammatory diseases? Nat Rev Immunol. doi: 10.1038/s41577-020-0312-7

Henry BM, Aggarwal G, Wong J et al. (2020) Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med. doi: 10.1016/j.ajem.2020.05.073

Tural Onur S, Altın S, Sokucu SN et al. (2021) Could ferritin level be an indicator of COVID-19 disease mortality? J Med Virol. doi: 10.1002/jmv.26543

Feld J, Tremblay D, Thibaud S et al. (2020) Ferritin levels in patients with COVID-19: A poor predictor of mortality and hemophagocytic lymphohistiocytosis. Int J Lab Hematol. doi: 10.1111/ijlh.13309

Cheng L, Li H, Li L et al. (2020) Ferritin in the coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Lab Anal. doi: 10.1002/jcla.23618

Gandini O, Criniti A, Ballesio L et al. (2020) Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19. J Infect. doi: 10.1016/j.jinf.2020.09.006

Gómez-Pastora J, Weigand M, Kim J et al. (2020) Hyperferritinemia in critically ill COVID-19 patients – Is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. doi: 10.1016/j.cca.2020.06.033

Liu T, Zhang J, Yang Y et al. (2020) The potential role of IL-6 in monitoring severe case of coronavirus disease 2019. medRxiv. doi: 10.1101/2020.03.01.20029769

Kernan KF, Carcillo JA (2017) Hyperferritinemia and inflammation. Int Immunol. doi: 10.1093/intimm/dxx031

Zhou F, Yu T, Du R et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. doi: 10.1016/S0140-6736(20)30566-3

Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. doi: 10.1111/jth.14768

Aggarwal M, Dass J, Mahapatra M (2020) Hemostatic Abnormalities in COVID-19: An Update. Indian J Hematol Blood Transfus. doi: 10.1007/s12288-020-01328-2

Zhang L, Yan X, Fan Q et al. (2020) D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. doi: 10.1111/jth.14859

Yao Y, Cao J, Wang Q et al. (2020) D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study. J Intensive Care. doi: 10.1186/s40560-020-00466-z

Joly BS, Siguret V, Veyradier A (2020) Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med. doi: 10.1007/s00134-020-06088-1

Ciceri F, Beretta L, Scandroglio AM et al. (2020) Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit. Care Resusc.


Copyright (c) 2021 Fidya Rahmadhany Arganita